Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lymphocyte subsets in primary sclerosing cholangitis.

K D Lindor, R H Wiesner, J A Katzmann

    Digestive Diseases and Sciences
    |July 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Editorial: is proton pump inhibitor use associated with worse outcomes in patients with liver abscesses?

    Alimentary pharmacology & therapeutics·2018
    Same author

    Review article: the evidence that vancomycin is a therapeutic option for primary sclerosing cholangitis.

    Alimentary pharmacology & therapeutics·2018
    Same author

    Prevalence of myeloma precursor state monoclonal gammopathy of undetermined significance in 12372 individuals 10-49 years old: a population-based study from the National Health and Nutrition Examination Survey.

    Blood cancer journal·2017
    Same author

    Quantitation of circulating wild-type alpha-1-antitrypsin in heterozygous carriers of the S and Z deficiency alleles.

    Respiratory research·2015
    Same author

    Editorial: Betaretrovirus in biliary epithelia of patients with autoimmune and cryptogenic liver disease.

    Alimentary pharmacology & therapeutics·2015
    Same author

    Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12,482 persons from the National Health and Nutritional Examination Survey.

    Leukemia·2014

    Primary sclerosing cholangitis (PSC) is linked to immune system abnormalities. Patients with PSC show reduced T cells and increased B cells, suggesting a defect in immune regulation not solely due to liver disease.

    Area of Science:

    • Immunology
    • Hepatology
    • Gastroenterology

    Background:

    • Primary sclerosing cholangitis (PSC) is a chronic liver disease with uncertain pathogenesis.
    • Immunoregulatory abnormalities are hypothesized to play a role in PSC development.
    • Understanding lymphocyte subset alterations can elucidate immune dysregulation in PSC.

    Purpose of the Study:

    • To investigate lymphocyte subset profiles in patients with PSC.
    • To determine if observed immunoregulatory abnormalities are associated with disease severity or other conditions.
    • To test the hypothesis that immune dysregulation is central to PSC pathogenesis.

    Main Methods:

    • Peripheral blood samples were collected from 33 PSC patients and controls.
    • Lymphocyte subsets, including T cells (Leu-2a/suppressor-cytotoxic, Leu-3a/helper) and B cells, were quantified.

    Related Experiment Videos

  • Statistical comparisons were made between PSC patients, cirrhotic/non-cirrhotic PSC patients, and controls.

    • Main Results:

    • PSC patients exhibited a significant reduction in total T cells, primarily due to decreased Leu-2a (suppressor/cytotoxic) cells.
    • The ratio of Leu-3a (helper) to Leu-2a (suppressor/cytotoxic) cells was significantly elevated in PSC patients compared to controls.
    • B cell numbers and percentages were significantly increased in PSC patients, correlating with disease stage and biochemical markers.

    Conclusions:

    • The observed alterations in T and B cell subsets suggest a defect in immunoregulation in primary sclerosing cholangitis.
    • These immunoregulatory abnormalities are not solely secondary to advanced liver disease.
    • The findings appear independent of concomitant chronic ulcerative colitis or obstructive jaundice.